NEWS
- Advances in TROP-2 Directed ADCs
- Development of PD-L1 Antibody Drug Conjugates (ADC)
- Bispecific Antibody Drug Conjugates (ADCs): Emerging Trends
- Nectin-4: New Antibody-Drug Conjugate (ADC) Target
- New Oncology Trends: ADCs, Bispecific Antibodies & CAR-T Cell
- Aptamer-Drug Conjugate (ApDC): Current Research Progress
- FRα Targeting ADCs for Ovarian cancer
- ADC Drugs Targeting Claudin18.2
- Maytansinoids as Payloads of ADCs: DM1, DM4
- Emerging Antibody–siRNA Conjugates (ARC)